About 62,900 results
Open links in new tab
Mayank Mamtani - B. Riley Financial
Mayank Mamtani - B. Riley Securities - LinkedIn
Mayank Mamtani - Analyst at B. Riley Securities - Stock Analysis
B. Riley upgrades Cognition Therapeutics to Buy on Lewy bodies …
B. Riley Strengthens Position as Leading Small- and Mid-Cap …
Maintained Buy Rating for Lineage Cell Therapeutics on Robust …
B.Riley Financial Reaffirms Their Buy Rating on Altimmune (ALT)
Strategic Transformation and Growth Prospects: Mayank Mamtani…
Vaxart spikes as B. Riley upgrades at long last after BARDA funding - MSN
- Some results have been removed